TrialEMBO molecular medicine2026

The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients.

Marijo Bilusic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.